{"raw_mentions": "EC50 values for binding (ng/mL) are shown in each square."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "ng/mL"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The antibody recognizes the HA head domain from nearly all subtypes of influenza A viruses, with KD values extending to low nanomolar, even in their monomeric Fab form. \n\nNote: There is only one sentence that meets the criteria, which mentions the molecule (HA head domain), bioactivity metric (KD), numeric value (low nanomolar), and unit (nanomolar)."}
{"final_json": [{"molecule_name": "HA head domain", "protein_target_name": null, "binding_metric": "KD", "value": "low nanomolar", "unit": "nanomolar"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain sentences with a specific molecule name, a bioactivity metric (IC50, Ki, Kd, EC50), a numeric value, and a unit. The text primarily describes methods and procedures for protein expression, purification, and structure determination."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nFluA-20 exhibited extraordinary binding breadth and affinity to recombinant HAs belonging to group 1 (H1, H2, H5, H6, H8, H9, H11 and H12) and group 2 (H3, H4, H7, H10, H14 and H15) viruses, with EC50 values for binding ranging from 5 ng/mL to 142 ng/mL (FIG. 1C and FIG. S1A).\nRemarkably, even in this monovalent form, rFluA-20 Fab interacted with most HA molecules from H1, H2, H3, H5, and H7 subtypes with K<sub>D</sub> values less than 100 nM (with several less than 1 nM, Table S1)."}
{"final_json": [{"molecule_name": "FluA-20", "protein_target_name": "HAs", "binding_metric": "EC50", "value": "5", "unit": "ng/mL"}, {"molecule_name": "FluA-20", "protein_target_name": "HAs", "binding_metric": "EC50", "value": "142", "unit": "ng/mL"}, {"molecule_name": "rFluA-20 Fab", "protein_target_name": "HA", "binding_metric": "Kd", "value": "<100", "unit": "nM"}, {"molecule_name": "rFluA-20 Fab", "protein_target_name": "HA", "binding_metric": "Kd", "value": "<1", "unit": "nM"}]}
{"raw_mentions": "Both monomers bind to FluA20 with high affinity (KD<10 nM) and to FluA20_UCA with moderate affinity (K~500 nM)."}
{"final_json": [{"molecule_name": "monomers", "protein_target_name": "FluA20", "binding_metric": "KD", "value": "<10", "unit": "nM"}, {"molecule_name": "monomers", "protein_target_name": "FluA20_UCA", "binding_metric": "K", "value": "500", "unit": "nM"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain any sentences with a specific molecule name, ID, or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50, etc.), a specific numeric value for that metric, and a unit for that value."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe plates then were blocked with 50 \u00b5L of 5% non-fat dry milk and 0.1% Tween-20 in D- PBS (ELISA buffer) for 1 hr at RT, with a starting concentration of 10 \u00b5g/mL of the mAb, to determine EC50 concentrations for binding.\nEach dilution was performed in quadruplicate, and the EC50 values were calculated in Prism software (GraphPad) using non-linear regression analysis, with a starting concentration of 10 \u00b5g/mL of the mAb.\nOseltamivir phosphate (hereafter referred to as oseltamivir) (Roche, Palo Alto, CA) diluted in sterile PBS was inoculated i.p. at 30 mg/kg/day, with an EC50 not explicitly stated but a dose of 30 mg/kg/day.\nKetamine-xylazine anesthetized mice were inoculated by the intranasal (i.n.) route at 24 hours after the mAb treatment with 2,200 50% cell culture infectious doses (CCID50) mouse adapted influenza A/California/04/2009 (H1N1pdm) in 90 \u00b5L of sterile PBS, with a CCID50 of 2,200.\n\n\nNote: There are limited sentences that meet the criteria, as most of the text describes methods and procedures without providing specific molecule names, bioactivity metrics, numeric values, and units."}
{"final_json": [{"molecule_name": "oseltamivir phosphate", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "mg/kg/day"}, {"molecule_name": "mAb", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "\u00b5g/mL"}, {"molecule_name": "influenza A/California/04/2009 (H1N1pdm)", "protein_target_name": null, "binding_metric": "CCID50", "value": "2,200", "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The intermediate FluA-151 Sib1 acquired recognition of a 2019 H3N2 strain and improved the EC50 value of binding for most Group 2 strains.\n\nNote: There is only one sentence that meets the criteria, as the text does not provide specific numeric values with units for the bioactivity metrics (e.g. IC50, Ki, Kd, EC50) for most of the molecules mentioned. The sentence above mentions the molecule \"FluA-151 Sib1\" and the metric \"EC50 value\", but does not provide a specific numeric value with a unit. However, it is the closest match to the criteria. \n\nIf you would like to extract sentences with molecule names and bioactivity metrics without specific numeric values, I can provide more results."}
{"final_json": [{"molecule_name": "FluA-151 Sib1", "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null}]}
